Contact a patient coordinator!

(855) 882-1292

Frequently Asked Questions (FAQ) About Cellular Therapy Treatment

As you begin to research cellular therapy treatment as an option to help you recapture your quality of life from chronic lung disease, it’s common to have questions about the process and outcomes. Take a moment to read through some of our frequently asked questions, and feel free to contact our team with any additional questions you may have.

Why Choose the Lung Health Institute?

At the Lung Health Institute, we are committed to helping patients find relief from chronic lung diseases. Many of the members of our medical team have a personal connection to lung disease, which makes us passionate about helping patients overcome the struggles of living with these chronic diseases. Unlike traditional treatments that simply mask the symptoms of lung disease, our cellular therapy targets the source of your symptoms and helps to reduce inflammation in the lungs so you can Breathe Easier.

What is Regenerative Medicine?

Regenerative medicine focuses on using the healing power of the body’s own cells to regenerate healthy tissue in the body. Specific to our cellular therapy, our treatment aims to regenerate healthy tissue and reduce inflammation in the lungs by using the platelets from a patient’s own body.

What are Cells?

Cells are often referred to as the building blocks of life because every living organism has cells. The term “autologous cells” that we use in reference to our cellular therapy simply means adult cells produced from the patient’s own body. Certain cells have the power to regenerate, which is why they are often the crux of regenerative medicine.

How are Cells Used by the Lung Health Institute?

Our cellular therapy treatment requires cells to be harvested from the patient’s body and then injected back into the body in order to target and reduce inflammation in the lungs. Now, that process might sound a little intense, but in reality it’s a quick, minimally invasive, outpatient procedure that looks a lot like donating blood and then getting an IV treatment. We are happy to walk you through exactly what this process looks like when you schedule a free consultation.

Are Cellular Therapies Painful?

Our cellular therapy treatment is a minimally invasive, outpatient procedure that requires no overnight stay and no recovery time. 95 percent of our patients are satisfied with our treatment process. While everyone’s tolerance of pain is different, we do find that most of our patients are pleasantly surprised with how simple our treatment process is.

Am I a Candidate?

To determine if you are a candidate for our cellular therapy treatment, please contact our team today to review your medical records and schedule you for a free consultation.

Is There a Risk of Rejection by the Body When Using Autologous Cells?

There is an extremely low risk of rejection of the autologous cells because they come from the patient’s own body. In fact, the risk of rejection of these cells is almost non-existent.

Why aren’t More Doctors Performing This Procedure?

Regenerative medicine is still a growing field, and not every medical school is up to date with regenerative medicine technology. To ensure our patients are receiving the best and latest treatment, our doctors are required to receive additional training for regenerative medicine for lung diseases.

What is the Life Expectancy of Someone with COPD and Does COPD Shorten Lifespan?

COPD can sometimes impact the life expectancy of a patient, often due to the complications that occur with not receiving enough oxygen to the body. However, there is no definite life expectancy rate for someone with COPD because everyone is different, and the disease can progress at different rates for different people. While there is no cure for the condition, there are many treatments available to help alleviate the symptoms.

What is the Life Expectancy of Someone with Pulmonary Fibrosis?

There is no set life expectancy number for patients with pulmonary fibrosis. The condition is progressive and can worsen at different rates for each person. There is no cure for pulmonary fibrosis, but there are treatments available to help patients Breathe Easier.

What is the Life Expectancy of Someone with Emphysema?

Patients suffering from emphysema may be diagnosed with a lower life expectancy rate due to complications that can arise from a lack of oxygen to the major organs in the body. However, there is no set number for life expectancy for this condition because every patient is different and this disease can progress differently. While there is no cure for emphysema, there are treatment options available.

What Does the BODE Index Stand For?

The BODE Index stands for:

  • Body Mass
  • Obstruction of Airflow
  • Dyspnea (difficulty breathing)
  • Exercise Capacity

It is used by doctors to categorize certain lung disease into stages, such as stage 3 COPD and so forth. This index helps doctors determine how the disease is impacting a patient’s life so they can estimate the progression of the disease.

What is the GOLD System?
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) developed the GOLD System. This system uses parts of the pulmonary function test to categorize chronic lung disease into four stages, as follows:

Stage 1: Very mild COPD with a FEV1 about 80 percent or more of normal.
Stage 2: Moderate COPD with a FEV1 between 50 and 80 percent of normal.
Stage 3: Severe emphysema with FEV1 between 30 and 50 percent of normal.
Stage 4: Very severe COPD with lower FEV1 than Stage 3, or those with Stage 3 FEV1 and low blood oxygen levels.

FREE CONSULTATION

Find out if you're a candidate!
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

 

Patients Treated

85% Find Improvement^

Based on patient surveys, 85% of patients report quality-of-life improvements at three months of treatment.

95% Patient Satisfaction*

Based on patient surveys following treatment.

Speak with a patient coordinator today to learn more about lung disease treatments. (855) 882-1292

FREE CONSULTATION

Find out if you're a candidate.

Every day we are changing people’s lives. Our duty and obligation is to help our patients, and we know we are doing something special for them. We measure our success by our patients’ success and their satisfaction with our services and the care they receive from our dedicated staff.

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